
Raymond J Henley Iii
Examiner (ID: 13341, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 1614, 1629, 1621, 2899 |
| Total Applications | 4270 |
| Issued Applications | 3011 |
| Pending Applications | 581 |
| Abandoned Applications | 704 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15360679
[patent_doc_number] => 20200016104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF FAT INFILTRATION IN MUSCLE
[patent_app_type] => utility
[patent_app_number] => 16/446328
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16446328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/446328 | Compositions and methods for the treatment of fat infiltration in muscle | Jun 18, 2019 | Issued |
Array
(
[id] => 15781291
[patent_doc_number] => 10624344
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-04-21
[patent_title] => Composition and method for protecting plant against disease and pest
[patent_app_type] => utility
[patent_app_number] => 16/442127
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3115
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16442127
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/442127 | Composition and method for protecting plant against disease and pest | Jun 13, 2019 | Issued |
Array
(
[id] => 15206001
[patent_doc_number] => 20190365687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/436468
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/436468 | Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use | Jun 9, 2019 | Issued |
Array
(
[id] => 15239509
[patent_doc_number] => 20190374540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => PYRIMETHAMINE-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/433679
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433679 | Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof | Jun 5, 2019 | Issued |
Array
(
[id] => 15264491
[patent_doc_number] => 20190380979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DEPRESSION WITH FENFLURAMINE
[patent_app_type] => utility
[patent_app_number] => 16/432468
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16432468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/432468 | Compositions and methods for treating respiratory depression with fenfluramine | Jun 4, 2019 | Issued |
Array
(
[id] => 15912923
[patent_doc_number] => 10653683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Tiotropium inhalation solution for nebulization
[patent_app_type] => utility
[patent_app_number] => 16/429908
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10038
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429908 | Tiotropium inhalation solution for nebulization | Jun 2, 2019 | Issued |
Array
(
[id] => 15205993
[patent_doc_number] => 20190365683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND THE TREATMENT OF OVERACTIVE BLADDER
[patent_app_type] => utility
[patent_app_number] => 16/428657
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428657
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428657 | Pharmaceutical compositions and the treatment of overactive bladder | May 30, 2019 | Issued |
Array
(
[id] => 14864705
[patent_doc_number] => 20190282594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/427621
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427621
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427621 | BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | May 30, 2019 | Abandoned |
Array
(
[id] => 14864589
[patent_doc_number] => 20190282536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH THE INHIBITION OF EGFR
[patent_app_type] => utility
[patent_app_number] => 16/424382
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424382 | Method for preventing or treating diseases associated with the inhibition of EGFR | May 27, 2019 | Issued |
Array
(
[id] => 17005341
[patent_doc_number] => 20210236502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => THERAPEUTIC OR PREVENTING AGENT FOR NEPHROTIC SYNDROME INCLUDING INDOLE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/056931
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056931 | Therapeutic or preventing agent for nephrotic syndrome including indole compound | May 23, 2019 | Issued |
Array
(
[id] => 19012997
[patent_doc_number] => 11919912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Modulators of methyl modifying enzymes, compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/057225
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7404
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057225 | Modulators of methyl modifying enzymes, compositions and uses thereof | May 16, 2019 | Issued |
Array
(
[id] => 19273229
[patent_doc_number] => 12023336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Antiviral drug compounds and composition thereof
[patent_app_type] => utility
[patent_app_number] => 17/055321
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 4525
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055321 | Antiviral drug compounds and composition thereof | May 9, 2019 | Issued |
Array
(
[id] => 18948098
[patent_doc_number] => 11891379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Deuterated Defactinib compound and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/054080
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4968
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054080 | Deuterated Defactinib compound and use thereof | May 5, 2019 | Issued |
Array
(
[id] => 16992085
[patent_doc_number] => 20210230505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => BRANCHED FATTY ACIDS AND ESTERS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/053580
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053580 | Branched fatty acids and esters thereof | May 2, 2019 | Issued |
Array
(
[id] => 19076429
[patent_doc_number] => 11945779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cells
[patent_app_type] => utility
[patent_app_number] => 17/052865
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9789
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052865 | Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cells | May 1, 2019 | Issued |
Array
(
[id] => 15615843
[patent_doc_number] => 20200078326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => READY-TO-USE TRANEXAMIC ACID INTRAVENOUS SOLUTION
[patent_app_type] => utility
[patent_app_number] => 16/392865
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16392865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/392865 | Ready-to-use tranexamic acid intravenous solution | Apr 23, 2019 | Issued |
Array
(
[id] => 17798999
[patent_doc_number] => 11413265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Formulations and compositions of Cabazitaxel
[patent_app_type] => utility
[patent_app_number] => 16/982252
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17301
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982252 | Formulations and compositions of Cabazitaxel | Apr 18, 2019 | Issued |
Array
(
[id] => 15224969
[patent_doc_number] => 10500188
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-12-10
[patent_title] => Use of a polyenylpyrrole derivative in preparation of anti-oral cancer drugs
[patent_app_type] => utility
[patent_app_number] => 16/385198
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 3523
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16385198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/385198 | Use of a polyenylpyrrole derivative in preparation of anti-oral cancer drugs | Apr 15, 2019 | Issued |
Array
(
[id] => 17383806
[patent_doc_number] => 20220031658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => LASOFOXIFENE TREATMENT OF BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/045969
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045969
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045969 | Lasofoxifene treatment of breast cancer | Apr 8, 2019 | Issued |
Array
(
[id] => 15694271
[patent_doc_number] => 10603296
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-03-31
[patent_title] => Compositions and methods for diagnosis and treatment of neuromuscular disorders
[patent_app_type] => utility
[patent_app_number] => 16/377993
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 23343
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377993 | Compositions and methods for diagnosis and treatment of neuromuscular disorders | Apr 7, 2019 | Issued |